Gene · 7436
Papers2,532
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,532
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum triglycerides level is independently associated with renal outcomes in patients with non-dialysis chronic kidney disease: Results from KNOW-CKD study. | Front Nutr | 2022 | 36505239 | PubTator, text mining | PubMed |
| Genome-wide analysis of a cellular exercise model based on electrical pulse stimulation. | Sci Rep | 2022 | 36481702 | PubTator, text mining | PubMed |
| Liver-derived metabolites as signaling molecules in fatty liver disease. | Cell Mol Life Sci | 2022 | 36477411 | PubTator, text mining | PubMed |
| Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review. | Cardiovasc Diabetol | 2022 | 36471375 | PubTator, text mining | PubMed |
| What role for cellular metabolism in the control of hepatitis viruses? | Front Immunol | 2022 | 36466918 | PubTator, text mining | PubMed |
| Immunomodulatory role of metalloproteinase ADAM17 in tumor development. | Front Immunol | 2022 | 36466812 | PubTator, text mining | PubMed |
| Treatment of Nonalcoholic Steatohepatitis by Obeticholic Acid: Current Status. | Euroasian J Hepatogastroenterol | 2022 | 36466097 | PubTator, text mining | PubMed |
| The role of FGF21 and its analogs on liver associated diseases. | Front Med (Lausanne) | 2022 | 36457562 | PubTator, text mining | PubMed |
| The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. | Cardiovasc Diabetol | 2022 | 36434633 | PubTator, text mining | PubMed |
| PPARγ Gene as a Possible Link between Acquired and Congenital Lipodystrophy and its Modulation by Dietary Fatty Acids. | Nutrients | 2022 | 36432429 | PubTator, text mining | PubMed |
| Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets. | Int J Mol Sci | 2022 | 36430837 | PubTator, text mining | PubMed |
| Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis. | Front Cardiovasc Med | 2022 | 36426222 | PubTator, text mining | PubMed |
| Autism spectrum disorders pathogenesis: Toward a comprehensive model based on neuroanatomic and neurodevelopment considerations. | Front Neurosci | 2022 | 36408388 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system. | Front Neurosci | 2022 | 36408381 | PubTator, text mining | PubMed |
| Multi-omics studies reveal ameliorating effects of physical exercise on neurodegenerative diseases. | Front Aging Neurosci | 2022 | 36389059 | PubTator, text mining | PubMed |
| Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: Insights and future perspectives. | Asian J Pharm Sci | 2022 | 36382305 | PubTator, text mining | PubMed |
| Impact of High-Density Lipoproteins on Sepsis. | Int J Mol Sci | 2022 | 36361756 | PubTator, text mining | PubMed |
| Drug Resistance in Cancers: A Free Pass for Bullying. | Cells | 2022 | 36359776 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Protection by Dendrobium Nobile Alkaloids (DNLA) against Chronic Alcoholic Liver Injury in Mice. | Biomedicines | 2022 | 36359319 | PubTator, text mining | PubMed |
| Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia. | Biomedicines | 2022 | 36359273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7436/papers?page=15